{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T22:40:21Z","timestamp":1773528021538,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T00:00:00Z","timestamp":1532995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministry of Science and Higher Education through Medical University of Lublin","award":["MNmb227"],"award-info":[{"award-number":["MNmb227"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s12253-018-0459-8","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T05:29:20Z","timestamp":1533014960000},"page":"1035-1045","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, XPC, XPD and XPG Genes, Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7399-8340","authenticated-orcid":false,"given":"Rados\u0142aw","family":"Mlak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwona","family":"Homa-Mlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Powr\u00f3zek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzanna","family":"Ciesielka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Kozio\u0142","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz","family":"Milanowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Ma\u0142ecka-Massalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,31]]},"reference":[{"issue":"1","key":"459_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7\u201330","journal-title":"CA Cancer J Clin"},{"key":"459_CR2","doi-asserted-by":"crossref","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) Non-Small Cell Lung Cancer Version 4.2016 www.nccn.org Accessed 1 July 2017","DOI":"10.1007\/s10330-018-0325-5"},{"issue":"9","key":"459_CR3","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1200\/JCO.2014.59.0489","volume":"33","author":"GM Blumenthal","year":"2015","unstructured":"Blumenthal GM, Karuri SW, Zhang H, Zhang L, Khozin S, Kazandjian D, Tang S, Sridhara R, Keegan P, Pazdur R (2015) Overall response rate, progression-free survival, and overall survival with targeted and standard therapies in advanced non-small-cell lung cancer: US Food and Drug Administration trial-level and patient-level analyses. J Clin Oncol 33(9):1008\u20131014","journal-title":"J Clin Oncol"},{"key":"459_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.cllc.2013.12.002","volume":"15","author":"C Gridelli","year":"2014","unstructured":"Gridelli C, de Marinis F, Cappuzzo F, di Maio M, Hirsch FR, Mok T, Morgillo F, Rosell R, Spigel DR, Yang JCH, Ciardiello F (2014) Treatment of advanced non-small-cell lung cancer with epidermal growth factor receptor (EGFR) mutation or ALK gene rearrangement: results of an international expert panel meeting of the Italian Association of Thoracic Oncology. Clin Lung Cancer 15:173\u2013181","journal-title":"Clin Lung Cancer"},{"key":"459_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cllc.2013.11.009","volume":"15","author":"GR Simon","year":"2014","unstructured":"Simon GR, Somaiah N (2014) A tabulated summary of targeted and biologic therapies for non-small-cell lung cancer. Clin Lung Cancer 15:21\u201351","journal-title":"Clin Lung Cancer"},{"issue":"10","key":"459_CR6","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/phar.1643","volume":"35","author":"NM La-Beck","year":"2015","unstructured":"La-Beck NM, Jean GW, Huynh C et al (2015) Immune checkpoint inhibitors: new insights and current place in Cancer therapy. Pharmacotherapy 35(10):963\u2013976","journal-title":"Pharmacotherapy"},{"issue":"1","key":"459_CR7","first-page":"435","volume":"34","author":"GJ Peters","year":"2014","unstructured":"Peters GJ, Avan A, Ruiz MG, Orsini V, Avan A, Giovannetti E, Smit EF (2014) Predictive role of repair enzymes in the efficacy of cisplatin combinations in pancreatic and lung cancer. Anticancer Res 34(1):435\u2013442","journal-title":"Anticancer Res"},{"issue":"7\u20138","key":"459_CR8","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.biocel.2007.05.006","volume":"39","author":"GR Simon","year":"2007","unstructured":"Simon GR, Ismail-Khan R, Bepler G (2007) Nuclear excision repair-based personalized therapy for non-small cell lung cancer: from hypothesis to reality. Int J Biochem Cell Biol 39(7\u20138):1318\u20131328","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"459_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.canlet.2014.07.023","volume":"353","author":"I Sullivan","year":"2014","unstructured":"Sullivan I, Salazar J, Majem M, Pallar\u00e9s C, del R\u00edo E, P\u00e1ez D, Baiget M, Barnadas A (2014) Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Cancer Lett 353(2):160\u2013166","journal-title":"Cancer Lett"},{"key":"459_CR10","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1002\/cncr.26522","volume":"118","author":"GR Simon","year":"2012","unstructured":"Simon GR, Schell MJ, Begum M, Kim J, Chiappori A, Haura E, Antonia S, Bepler G (2012) Preliminary indication of survival benefit from ERCC1 and RRM1-tailored chemotherapy in patients with advanced nonsmall cell lung cancer: evidence from an individual patient analysis. Cancer 118:2525\u20132531","journal-title":"Cancer"},{"key":"459_CR11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00280-014-2513-x","volume":"74","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Zhu X, Zhang L, Sun S, Huang J, Lin Y (2014) A prospective study of biomarker-guided chemotherapy in patients with non-small cell lung cancer. Cancer Chemother Pharmacol 74:839\u2013846","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"459_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00280-011-1670-4","volume":"69","author":"M Joerger","year":"2012","unstructured":"Joerger M, Burgers JA, Baas P, Doodeman VD, Smits PHM, Jansen RS, Vainchtein LD, Rosing H, Huitema ADR, Beijnen JH, Schellens JHM (2012) Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin\/gemcitabine. Cancer Chemother Pharmacol 69(1):25\u201333","journal-title":"Cancer Chemother Pharmacol"},{"key":"459_CR13","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1093\/hmg\/ddq392","volume":"19","author":"A Murphy","year":"2010","unstructured":"Murphy A, Chu JH, Xu M, Carey VJ, Lazarus R, Liu A, Szefler SJ, Strunk R, DeMuth K, Castro M, Hansel NN, Diette GB, Vonakis BM, Franklin Adkinson N Jr, Klanderman BJ, Senter-Sylvia J, Ziniti J, Lange C, Pastinen T, Raby BA (2010) Mapping of numerous disease-associated expression polymorphisms in primary peripheral blood CD4+ lymphocytes. Hum Mol Genet 19:4745\u20134757","journal-title":"Hum Mol Genet"},{"issue":"5","key":"459_CR14","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00280-013-2127-8","volume":"71","author":"W Zhao","year":"2013","unstructured":"Zhao W, Hu XJ et al (2013) Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer. Cancer Chemother Pharmacol 71(5):1287\u20131295","journal-title":"Cancer Chemother Pharmacol"},{"key":"459_CR15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.lungcan.2013.08.018","volume":"82","author":"F Mazzoni","year":"2013","unstructured":"Mazzoni F, Cecere FL, Meoni G, Giuliani C, Boni L, Camerini A, Lucchesi S, Martella F, Amoroso D, Lucherini E, Torricelli F, di Costanzo F (2013) Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer. Lung Cancer 82:288\u2013293","journal-title":"Lung Cancer"},{"issue":"4","key":"459_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3816\/CLC.2003.n.004","volume":"4","author":"C Camps","year":"2003","unstructured":"Camps C, Sarries C, Roig B, Javier S\u00e1nchez J, Queralt C, Sancho E, Martinez N, Tar\u00f3n M, Rosell R (2003) Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine\/cisplatin-treated advanced non-small-cell lung cancer patients. Clin Lung Cancer 4(4):237\u2013241","journal-title":"Clin Lung Cancer"},{"issue":"6","key":"459_CR17","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/JTO.0b013e31824fe98c","volume":"7","author":"WY Liao","year":"2012","unstructured":"Liao WY, Shih JY, Chang GC, Cheng YK, Yang JCH, Chen YM, Yu CJ (2012) Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine\/platinum. J Thorac Oncol 7(6):973\u2013981","journal-title":"J Thorac Oncol"},{"issue":"6","key":"459_CR18","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1158\/1078-0432.CCR-07-1364","volume":"14","author":"C Tibaldi","year":"2008","unstructured":"Tibaldi C, Giovannetti E, Vasile E, Mey V, Laan AC, Nannizzi S, di Marsico R, Antonuzzo A, Orlandini C, Ricciardi S, del Tacca M, Peters GJ, Falcone A, Danesi R (2008) Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine\/cisplatin-treated advanced non-small cell lung cancer patients. Clin Cancer Res 14(6):1797\u20131803","journal-title":"Clin Cancer Res"},{"issue":"4","key":"459_CR19","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/annonc\/mdj135","volume":"17","author":"R Pe\u00f1as de las","year":"2006","unstructured":"de las Pe\u00f1as R, Sanchez-Ronco M, Alberola V et al (2006) Polymorphisms in DNA repair genes modulate survival in cisplatin\/gemcitabine-treated non-small-cell lung cancer patients. Ann Oncol 17(4):668\u2013675","journal-title":"Ann Oncol"},{"issue":"6","key":"459_CR20","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.7314\/APJCP.2012.13.6.2583","volume":"13","author":"ZY Zhang","year":"2012","unstructured":"Zhang ZY, Tian X, Wu R, Liang Y, Jin XY (2012) Predictive role of ERCC1 and XPD genetic polymorphisms in survival of Chinese non-small cell lung cancer patients receiving chemotherapy. Asian Pac J Cancer Prev 13(6):2583\u20132586","journal-title":"Asian Pac J Cancer Prev"},{"issue":"11","key":"459_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079864","volume":"8","author":"Q Qin","year":"2013","unstructured":"Qin Q, Zhang C, Yang X, Zhu H, Yang B, Cai J, Cheng H, Ma J, Lu J, Zhan L, Liu J, Liu Z, Xu L, Sun X (2013) Polymorphisms in XPD gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients: a meta-analysis of 24 studies. PLoS One 8(11):e79864","journal-title":"PLoS One"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-018-0459-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-018-0459-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-018-0459-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T01:58:59Z","timestamp":1693792739000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-018-0459-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,31]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["459"],"URL":"https:\/\/doi.org\/10.1007\/s12253-018-0459-8","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,31]]},"assertion":[{"value":"23 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All persons gave their informed consent prior to their inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.This article does not contain any studies with animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Studies"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}